PF-Atlas › Weekly Digest
Weekly IPF Research Digest
A plain-language summary of what moved in idiopathic pulmonary fibrosis research each week — new and updated clinical trials, fresh studies, where the best options stand today, and how close the field is to true regeneration. Written to be understood without a medical degree, grounded only in real trials and published papers.
- Week of Sept 15–22, 2026: A New Breathing-Test Trial Opens, PDE4 Inhibitors in the Spotlight
2026-09-15 → 2026-09-22 · Active weekOne new IPF trial opened this week, a dozen papers published, and research spotlights PDE4 inhibitors and side-effect profiles of the two mainstay drugs.
Medical disclaimer. This digest summarizes public clinical-trial and research data in plain language for information only. It is not medical advice, a treatment recommendation, or a promise of any outcome. Evidence changes; treatments described as investigational are not proven cures. Always verify with ClinicalTrials.gov, PubMed and a qualified pulmonologist before any decision.